Immunomodulatory therapy for febrile neutropenia without the risk of antibiotic resistance; Phase 1a clinical trials of a new drug indication.
aktheliapharma.com
We use cookies to improve your experience, analyze site usage, and support the continued development of our services. By clicking "Accept All", you consent to their use.